Sanofi India posted a strong June-quarter performance, with profit rising 20% as its diabetes portfolio continued to deliver double-digit growth. Higher operating efficiency also helped expand margins despite single-digit revenue growth.
Sanofi India posted a strong June-quarter performance, with profit rising 20% as its diabetes portfolio continued to deliver double-digit growth. Higher operating efficiency also helped expand margins despite single-digit revenue growth.